ReviewInternational journal of environmental research and public health2021
Malaysia's Health Systems Response to COVID-19.
Review in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of COVID-19 Pandemic on Healthcare Utilization among Patients with Type 2 Diabetes Mellitus: A Systematic Review.International journal of environmental research and public health · 2023Pooled it
- Enhancing COVID-19 Forecasting Accuracy in Malaysia Using a Hybrid ARIMA-LSTM Model With Exogenous Variables: A Time-Series Predictive Study.Health science reports · 2026Article
- Article
- COVID-19 legislative response and challenges in Republic of Korea.Frontiers in public health · 2026Review
- Scaling digital health in low- and middle-income countries: lessons from Malaysia's cross-sector capacity-building approach.Journal of global health · 2025Article
- Genomic surveillance reveals COVID-19 outbreak clusters in a tertiary center in Malaysia: A cross-sectional study.IJID regions · 2025Article
- Experts' Views on Factors Influencing Resource Allocation for Infectious Disease Emergencies Based on Humanitarian Principles: A Qualitative Study.AJPM focus · 2025Article
- Challenges faced by migrant populations in complying with public health measures during the COVID-19 pandemic in Malaysia: A qualitative study.BMJ public health · 2024Article
- Acceptance of Electronic Labeling for Medicinal Product Information Among Malaysian Hospital Patients: Cross-Sectional Study.Journal of medical Internet research · 2024Article
- Knowledge as a Predictor for Preparedness in Managing COVID-19 Among General Practitioners in Malaysia.Cureus · 2024Article
- Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018-2022.Journal of pharmaceutical policy and practice · 2024Article
- COVID-19 and migrants: lessons for pandemic preparedness from the Malaysian experience.Globalization and health · 2023Review
- National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics.Globalization and health · 2023Review
- Timeline of SARS-CoV-2 Transmission in Sabah, Malaysia: Tracking the Molecular Evolution.Pathogens (Basel, Switzerland) · 2023Article
- The Determinants of Non-compliance on Rabies Vaccination in North-West Peninsular Malaysia.Journal of epidemiology and global health · 2023Article
- Editorial: Public Health Data Challenges of the COVID-19 pandemic: A Sisyphean task!Frontiers in public health · 2022Article
- Identifying the preparedness components in COVID-19: Systematic literature review.Journal of education and health promotion · 2022Review
- Risk Communication in Early Containment of COVID-19 Pandemic in Iran: Implementation of the World Health Organization Strategic Preparedness and Response Plan (WHO-SPRP).Medical journal of the Islamic Republic of Iran · 2022Article
- COVID-19 clusters in Malaysia: characteristics, detection methods and modes of early transmission.Western Pacific surveillance and response journal : WPSARArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to highlight the COVID-19 response by the Ministry of Health (MOH) and the Government of Malaysia in order to share Malaysia's lessons and to improve future pandemic preparedness. The team conducted a rapid review using publicly available information from MOH, PubMed, and World Health Organisation (WHO) Global Research on Coronavirus Disease Database to compile Malaysia's responses during the COVID-19 pandemic. Measures taken between 31 December 2019 and 3 June 2020 were classified into domains as well as the pillars described in the WHO COVID-19 Strategic Preparedness and Response Plan (WHO SPRP). Malaysia's response incorporated all pillars in the WHO SPRP and consisted of five domains, (i) whole-of-government, (ii) cordon sanitaire/lockdown, (iii) equity of access to services and supports, (iv) quarantine and isolation systems, and (v) legislation and enforcement. Some crucial measures taken were activation of a centralised multi-ministerial coordination council where MOH acted as an advisor, with collaboration from non-government organisations and private sectors which enabled an effective targeted screening approach, provision of subsidised COVID-19 treatment and screening, isolation or quarantine of all confirmed cases, close contacts and persons under investigation, with all strategies applied irrespective of citizenship. This was provided for by way of the Prevention and Control of Infectious Diseases Act 1988. A combination of these measures enabled the nation to contain the COVID-19 outbreak by the end of June 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.